Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Prosthesis Failure × Cyclophosphamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 303 Precursor Cell Lymphoblastic Leukemia-Lymphoma 276 Lymphoma 255 Leukemia 225 Multiple Myeloma 212 Lymphoma, Large B-Cell, Diffuse 206 Lymphoma, Non-Hodgkin 205 Leukemia, Myeloid, Acute 203 Leukemia, Lymphocytic, Chronic, B-Cell 190 Myelodysplastic Syndromes 162 Lymphoma, Follicular 151 Hodgkin Disease 148 Burkitt Lymphoma 141 Lymphoma, Mantle-Cell 138 Recurrence 101 Lymphoma, B-Cell, Marginal Zone 101 Lymphoma, Large-Cell, Immunoblastic 85 Myeloproliferative Disorders 69 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 69 Melanoma 67 Neoplasms, Plasma Cell 66 Leukemia, Myelomonocytic, Chronic 65 Hematologic Neoplasms 64 Leukemia, Myeloid, Chronic-Phase 63 Leukemia, Myeloid, Accelerated Phase 63 Dendritic Cell Sarcoma, Interdigitating 61 Ovarian Neoplasms 54 Lymphoma, B-Cell 54 Blast Crisis 54 Triple Negative Breast Neoplasms 51

Interventions

Radiotherapy 1 Paclitaxel 1 Olanzapine 1 Megestrol Acetate 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01918124 2018-10-12

EC-0701

Fudan University

Phase 2 Completed

Prosthesis Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡